Laser-plasma accelerators can accelerate particles over distances that are up to 1,000 times shorter than those required by ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

A fundamental discovery in how the immune system organizes itself to respond better to external threats,” researchers find in study.

which already includes discovery pathways for both activated and memory B-cells. The new plasma B-cell service is projected to be of particular value to clients pursuing difficult targets in ...

plasma, cell lysates and tissue homogenates Offered through the Standard BioTools™ CAP/CLIA-accredited laboratory in Boulder, Colo. Single SOMAmer Reagents: a powerful antibody alternative for ...

Multiple myeloma (MM) is an incurable and biologically diverse blood cancer that begins with the uncontrolled growth of plasma cells in the bone marrow. One of plasma’s main roles is to produce ...

Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s ...

Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug ...